Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-Dexmedetomidine Adjunction in Balanced Anesthesia for Minimally Invasive Cardiac Valve Surgery
NCT07798089Phase 2Not yet recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Sep 2026
- Primary completion
- Dec 2026
01
Overview
A Phase 2 trial of dexmedetomidine in valvular heart disease (VHD), sponsored by Kafrelsheikh University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
valvular heart disease (VHD)
Beyond the preview
Go deeper on NCT07798089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07798089.